Owner 3-DIMENSIONAL PHARMACEUTICALS, INC.

Inventors Springer, Barry A.; Rent Zeperis, Dionisios; Bone, Roger F.; Askari, Hossein; Salemme, Francis R.

Agent Callinan

Pub. Number AU-A-2002330048

PCT Number PCT/US02/29661

PCT Pub. Number WO2004/010141

Priority 60/398,023 24.07.02 US

Filing date 20 September 2002

Wipo publication date 9 February 2004

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07K 004/00 Peptides having up to 20 amino acids in an undefined or only partially defined sequence

C07K 005/00 Peptides having up to four amino acids in a fully defined sequence

C07K 007/00 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 014/00 Peptides having more than 20 amino acids

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 017/00 Carrier-bound or immobilised peptides

G01N 033/567 Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

A61K 038/00 Medicinal preparations containing peptides

C07K 001/00 General processes for the preparation of peptides

C07K 002/00 Peptides of undefined number of amino acids